Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes,Source_Sheet,Source_DB
AMPK signaling pathway,3/120,2.0879996040351942E-6,3.1319994060527912E-5,0,0,254.84615384615384,3333.210339156145,PFKFB2;PCK1;FBP1,Gluconeogenesis,kegg
Citrate cycle (TCA cycle),2/30,2.1689044409521838E-5,1.3159080201269373E-4,0,0,475.40476190476193,5105.2306811411236,PC;PCK1,Gluconeogenesis,kegg
Fructose and mannose metabolism,2/33,2.6318160402538746E-5,1.3159080201269373E-4,0,0,429.33333333333331,4527.4279118472859,PFKFB2;FBP1,Gluconeogenesis,kegg
Pyruvate metabolism,2/47,5.3807352784853449E-5,2.0177757294320044E-4,0,0,295.55555555555554,2905.340794131333,PC;PCK1,Gluconeogenesis,kegg
Glycolysis / Gluconeogenesis,2/67,1.098341891953128E-4,3.2950256758593839E-4,0,0,204.41025641025641,1863.5140133125917,PCK1;FBP1,Gluconeogenesis,kegg
Glucagon signaling pathway,2/107,2.8058901406937699E-4,7.0147253517344253E-4,0,0,126.28571428571429,1032.8428108124656,PCK1;FBP1,Gluconeogenesis,kegg
Insulin signaling pathway,2/137,4.5955248238770628E-4,9.8475531940222768E-4,0,0,98.074074074074076,753.72450415314711,PCK1;FBP1,Gluconeogenesis,kegg
Proximal tubule bicarbonate reclamation,1/23,5.7372891133286473E-3,1.0757417087491214E-2,0,0,226.96590909090909,1171.3185051583378,PCK1,Gluconeogenesis,kegg
Pentose phosphate pathway,1/30,7.478192828541258E-3,1.2463654714235431E-2,0,0,172.12068965517241,842.66229614654151,FBP1,Gluconeogenesis,kegg
Adipocytokine signaling pathway,1/69,1.7132947269309973E-2,2.5043569231275025E-2,0,0,73.26102941176471,297.93443263412689,PCK1,Gluconeogenesis,kegg
PPAR signaling pathway,1/74,1.8365284102935021E-2,2.5043569231275025E-2,0,0,68.226027397260268,272.71943060410257,PCK1,Gluconeogenesis,kegg
Insulin resistance,1/108,2.6712437413131718E-2,3.3390546766414647E-2,0,0,46.467289719626166,168.33361194919559,PCK1,Gluconeogenesis,kegg
Thyroid hormone signaling pathway,1/121,2.9888950061789109E-2,3.4487250071295127E-2,0,0,41.40625,145.34696936891217,PFKFB2,Gluconeogenesis,kegg
FoxO signaling pathway,1/131,3.2326773605739184E-2,3.463582886329198E-2,0,0,38.20192307692308,131.10363216765762,PCK1,Gluconeogenesis,kegg
PI3K-Akt signaling pathway,1/354,8.5430009182989972E-2,8.5430009182989972E-2,0,0,13.910764872521247,34.22128624523743,PCK1,Gluconeogenesis,kegg
Glycolysis / Gluconeogenesis,16/67,6.0974258042615034E-40,1.768253483235836E-38,0,0,6253.1764705882351,564633.92759858875,TPI1;PKLR;ENO1;ENO2;HK2;HK1;PFKL;PKM;PGK1;PGAM4;PGK2;ALDOB;ALDOA;PFKM;GAPDH;PGM1,Gluconeogenesis,kegg
HIF-1 signaling pathway,11/109,9.0235462835487886E-22,1.3084142111145743E-20,0,0,371.99829931972789,18025.934472898207,PFKL;PGK1;ENO1;PGK2;ALDOB;ENO2;ALDOA;PFKM;GAPDH;HK2;HK1,Gluconeogenesis,kegg
Fructose and mannose metabolism,7/33,3.2357788378992367E-16,3.1279195433025952E-15,0,0,537.30384615384617,19164.065624243834,PFKL;TPI1;ALDOB;ALDOA;PFKM;HK2;HK1,Gluconeogenesis,kegg
Central carbon metabolism in cancer,6/70,1.7719954814112562E-11,1.2846967240231608E-10,0,0,169.76420454545453,4202.7386225078653,PFKL;PKM;PGAM4;PFKM;HK2;HK1,Gluconeogenesis,kegg
Pentose phosphate pathway,5/30,3.2664627416124712E-11,1.8814692880331741E-10,0,0,332.63333333333333,8031.3414747894849,PFKL;ALDOB;ALDOA;PFKM;PGM1,Gluconeogenesis,kegg
Galactose metabolism,5/31,3.8926950786893258E-11,1.8814692880331741E-10,0,0,319.82371794871796,7665.9616071157961,PFKL;PFKM;HK2;PGM1;HK1,Gluconeogenesis,kegg
Starch and sucrose metabolism,4/36,2.0684898383664146E-8,8.5694579018037178E-8,0,0,191.83653846153845,3394.3292284288705,HK2;PGM2L1;PGM1;HK1,Gluconeogenesis,kegg
Type II diabetes mellitus,4/46,5.7006926543655708E-8,2.0665010872075194E-7,0,0,146.08791208791209,2436.7599683023027,PKM;PKLR;HK2;HK1,Gluconeogenesis,kegg
RNA degradation,4/79,5.1595489775595E-7,1.6625213372136168E-6,0,0,81.673846153846156,1182.4124019621934,PFKL;ENO1;ENO2;PFKM,Gluconeogenesis,kegg
Glucagon signaling pathway,4/107,1.7464960007622619E-6,5.0648384022105592E-6,0,0,59.387602688573566,787.35484201255906,PFKL;PKM;PGAM4;PFKM,Gluconeogenesis,kegg
"Neomycin, kanamycin and gentamicin biosynthesis",2/5,6.7896847477175261E-6,1.7900077971255295E-5,0,0,888,10567.294169184646,HK2;HK1,Gluconeogenesis,kegg
Amino sugar and nucleotide sugar metabolism,3/48,8.6156298508488988E-6,2.0821105472884837E-5,0,0,94.942857142857136,1107.217198924578,HK2;PGM1;HK1,Gluconeogenesis,kegg
Purine metabolism,3/129,1.6684859274618911E-4,3.7220070689534493E-4,0,0,33.770408163265309,293.74932166565526,PKM;PKLR;PGM1,Gluconeogenesis,kegg
Insulin signaling pathway,3/137,1.9929076041466353E-4,4.1281657514466018E-4,0,0,31.741471215351812,270.46100411619,PKLR;HK2;HK1,Gluconeogenesis,kegg
Carbohydrate digestion and absorption,2/47,7.1874630037704445E-4,1.3027276694333931E-3,0,0,59.075555555555553,427.58899594765302,HK2;HK1,Gluconeogenesis,kegg
Pyruvate metabolism,2/47,7.1874630037704445E-4,1.3027276694333931E-3,0,0,59.075555555555553,427.58899594765302,PKM;PKLR,Gluconeogenesis,kegg
AMPK signaling pathway,2/120,4.5775015847456958E-3,7.4950732258765229E-3,0,0,22.44632768361582,120.90943213897548,PFKL;PFKM,Gluconeogenesis,kegg
Thyroid hormone signaling pathway,2/121,4.6521144160612902E-3,7.4950732258765229E-3,0,0,22.25658263305322,119.52749584638217,PFKL;PFKM,Gluconeogenesis,kegg
Shigellosis,2/246,1.8145310558352331E-2,2.7695474010116718E-2,0,0,10.786338797814208,43.246133282395348,HK2;HK1,Gluconeogenesis,kegg
Maturity onset diabetes of the young,1/26,2.188015065344143E-2,3.1726218447490073E-2,0,0,49.895000000000003,190.70744238188936,PKLR,Gluconeogenesis,kegg
"Glycine, serine and threonine metabolism",1/40,3.3474383104990776E-2,4.6226529049749165E-2,0,0,31.96153846153846,108.57254123777712,PGAM4,Gluconeogenesis,kegg
Inositol phosphate metabolism,1/73,6.0293950784224219E-2,7.9478389670113739E-2,0,0,17.283854166666668,48.542110579522607,TPI1,Gluconeogenesis,kegg
Non-alcoholic fatty liver disease,1/155,0.12393582001851285,0.15626690350160316,0,0,8.0474837662337659,16.803077119770684,PKLR,Gluconeogenesis,kegg
Pathogenic Escherichia coli infection,1/197,0.15493977178893165,0.17766254736475862,0,0,6.3096301020408161,11.765685914464035,GAPDH,Gluconeogenesis,kegg
Diabetic cardiomyopathy,1/203,0.15928366315461118,0.17766254736475862,0,0,6.1203589108910892,11.243519306184107,GAPDH,Gluconeogenesis,kegg
Viral carcinogenesis,1/203,0.15928366315461118,0.17766254736475862,0,0,6.1203589108910892,11.243519306184107,PKM,Gluconeogenesis,kegg
Salmonella infection,1/249,0.19189543678576401,0.20610991358470951,0,0,4.973538306451613,8.2103401899860859,GAPDH,Gluconeogenesis,kegg
Human papillomavirus infection,1/331,0.24709638779420101,0.25592125878685107,0,0,3.7221590909090909,5.2034919972731055,PKM,Gluconeogenesis,kegg
Alzheimer disease,1/369,0.27145562138777646,0.27145562138777646,0,0,3.3313519021739131,4.3439383334221482,GAPDH,Gluconeogenesis,kegg
Central carbon metabolism in cancer,5/70,5.6582857688413402E-11,1.5843200152755751E-9,0,0,383.19230769230768,9041.5432225481163,LDHB;LDHA;SLC2A1;SLC16A3;GLS,Gluconeogenesis,kegg
Glucagon signaling pathway,3/107,1.2215982179498698E-5,1.0343408050986165E-4,0,0,95.61057692307692,1081.6200311583434,LDHB;LDHA;SLC2A1,Gluconeogenesis,kegg
HIF-1 signaling pathway,3/109,1.2914801711522106E-5,1.0343408050986165E-4,0,0,93.797169811320757,1055.8875424616392,LDHB;LDHA;SLC2A1,Gluconeogenesis,kegg
Glutamatergic synapse,3/114,1.4776297215694522E-5,1.0343408050986165E-4,0,0,89.549549549549553,996.01362912671402,SLC1A3;GLUL;GLS,Gluconeogenesis,kegg
Arginine biosynthesis,2/22,4.1386405906523752E-5,2.3176387307653298E-4,0,0,285.3,2879.4068233054322,GLUL;GLS,Gluconeogenesis,kegg
Propanoate metabolism,2/34,1.0022949748932253E-4,4.6773765495017181E-4,0,0,178.20535714285714,1640.9234871537965,LDHB;LDHA,Gluconeogenesis,kegg
"Alanine, aspartate and glutamate metabolism",2/37,1.1890590002824753E-4,4.7562360011299011E-4,0,0,162.9061224489796,1472.2116476467231,GLUL;GLS,Gluconeogenesis,kegg
Pyruvate metabolism,2/47,1.9254963508295519E-4,6.7392372279034319E-4,0,0,126.64126984126985,1083.4358946139766,LDHB;LDHA,Gluconeogenesis,kegg
Cysteine and methionine metabolism,2/50,2.1804660985203623E-4,6.7836723065077943E-4,0,0,118.70833333333333,1000.8064198202925,LDHB;LDHA,Gluconeogenesis,kegg
Glycolysis / Gluconeogenesis,2/67,3.9199458726740105E-4,1.0975848443487229E-3,0,0,87.586813186813188,687.05395647589478,LDHB;LDHA,Gluconeogenesis,kegg
GABAergic synapse,2/89,6.9072394340393231E-4,1.7582064013918278E-3,0,0,65.366174055829234,475.72000128280672,GLUL;GLS,Gluconeogenesis,kegg
D-Glutamine and D-glutamate metabolism,1/5,2.24816055240216E-3,5.24570795560504E-3,0,0,624.59375,3808.5496634307242,GLS,Gluconeogenesis,kegg
Nitrogen metabolism,1/17,7.6254739654265415E-3,1.6424097771687934E-2,0,0,156.0546875,760.96335515960936,GLUL,Gluconeogenesis,kegg
Proximal tubule bicarbonate reclamation,1/23,1.0304464378507131E-2,2.0608928757014262E-2,0,0,113.46022727272727,519.10074055447171,GLS,Gluconeogenesis,kegg
Glyoxylate and dicarboxylate metabolism,1/30,1.3421829479327331E-2,2.5054081694744351E-2,0,0,86.043103448275858,370.92087702683546,GLUL,Gluconeogenesis,kegg
Adipocytokine signaling pathway,1/69,3.0630795282474307E-2,5.0450721641722387E-2,0,0,36.623161764705884,127.65916393890298,SLC2A1,Gluconeogenesis,kegg
Renal cell carcinoma,1/69,3.0630795282474307E-2,5.0450721641722387E-2,0,0,36.623161764705884,127.65916393890298,SLC2A1,Gluconeogenesis,kegg
Synaptic vesicle cycle,1/78,3.4563999521536423E-2,5.3766221477945547E-2,0,0,32.327922077922075,108.78160264941484,SLC1A3,Gluconeogenesis,kegg
Insulin secretion,1/86,3.8048266007532069E-2,5.5700685941666182E-2,0,0,29.273529411764706,95.692233477225784,SLC2A1,Gluconeogenesis,kegg
Bile secretion,1/90,3.9786204244047274E-2,5.5700685941666182E-2,0,0,27.952247191011235,90.12461522615385,SLC2A1,Gluconeogenesis,kegg
Insulin resistance,1/108,4.7572438567341321E-2,6.3429918089788428E-2,0,0,23.228971962616821,70.743873767188688,SLC2A1,Gluconeogenesis,kegg
Thyroid hormone signaling pathway,1/121,5.3160876149181691E-2,6.765929691714033E-2,0,0,20.698958333333334,60.739697372377059,SLC2A1,Gluconeogenesis,kegg
Necroptosis,1/159,6.9329571729623105E-2,8.4401217757802044E-2,0,0,15.690664556962025,41.876559557969401,GLUL,Gluconeogenesis,kegg
Diabetic cardiomyopathy,1/203,8.7744243721952803E-2,0.10236828434227828,0,0,12.245668316831683,29.797740052778707,SLC2A1,Gluconeogenesis,kegg
Human T-cell leukemia virus 1 infection,1/219,9.4359746489173127E-2,0.10568291606787392,0,0,11.337729357798166,26.764305493233458,SLC2A1,Gluconeogenesis,kegg
Huntington disease,1/306,0.12959081074079043,0.1360394717619009,0,0,8.0680327868852455,16.486003606054858,SLC1A3,Gluconeogenesis,kegg
MicroRNAs in cancer,1/310,0.13118091919897587,0.1360394717619009,0,0,7.9619741100323624,16.172185422589365,GLS,Gluconeogenesis,kegg
Pathways in cancer,1/531,0.21512272418387934,0.21512272418387934,0,0,4.589858490566038,7.0525314744408165,SLC2A1,Gluconeogenesis,kegg
Glutamatergic synapse,24/114,3.3103673075861E-53,9.2690284612410801E-52,0,0,2651.2,320370.87749837257,GRIA1;GRIA2;GRIK5;GRIK3;GRIK4;GRIK1;GRIK2;GRIN2C;GRIN2B;GRM1;GRIN2D;GRIN1;GRM3;GRM2;GRIN3B;GRM5;GRIN2A;GRIN3A;GRM4;GRM7;GRM6;GRM8;GRIA3;GRIA4,Gluconeogenesis,kegg
Neuroactive ligand-receptor interaction,26/341,4.0261739426540786E-47,5.6366435197157104E-46,0,0,511134,54603771.974538021,GRIA1;GRIA2;GRIK5;GRIK3;GRIK4;GRIK1;GRIK2;GRM1;GRM3;GRM2;GRM5;GRIN2A;GRM4;GRM7;GRM6;GRM8;GRIA3;GRIA4;GRID2;GRID1;GRIN2C;GRIN2B;GRIN2D;GRIN1;GRIN3B;GRIN3A,Gluconeogenesis,kegg
Nicotine addiction,11/40,3.4171031001404054E-24,3.189296226797712E-23,0,0,504.35632183908046,27252.010766267849,GRIA1;GRIA2;GRIN3B;GRIN2A;GRIN3A;GRIN2C;GRIN2B;GRIA3;GRIN2D;GRIN1;GRIA4,Gluconeogenesis,kegg
Amphetamine addiction,11/69,2.6432899449197139E-21,1.8503029614437997E-20,0,0,251.81149425287356,11931.398351502612,GRIA1;GRIA2;GRIN3B;GRIN2A;GRIN3A;GRIN2C;GRIN2B;GRIA3;GRIN2D;GRIN1;GRIA4,Gluconeogenesis,kegg
Cocaine addiction,10/49,1.5054405319176497E-20,8.4304669787388381E-20,0,0,319.47115384615387,14581.499291450133,GRM3;GRIA2;GRM2;GRIN3B;GRIN2A;GRIN3A;GRIN2C;GRIN2B;GRIN2D;GRIN1,Gluconeogenesis,kegg
Spinocerebellar ataxia,11/143,1.1895243927332457E-17,5.5511138327551469E-17,0,0,110.23333333333333,4295.8363243055555,GRIA1;GRIA2;GRIN3B;GRIN2A;GRIN3A;GRIN2C;GRIN2B;GRIA3;GRM1;GRIN2D;GRIN1,Gluconeogenesis,kegg
Long-term potentiation,9/67,9.0674927975861916E-17,3.6269971190344766E-16,0,0,181.78904665314403,6715.1511839293444,GRIA1;GRIA2;GRM5;GRIN2A;GRIN2C;GRIN2B;GRM1;GRIN2D;GRIN1,Gluconeogenesis,kegg
cAMP signaling pathway,11/216,1.2095684838971919E-15,4.233489693640172E-15,0,0,70.718373983739838,2429.0709685859565,GRIA1;GRIA2;GRIN3B;GRIN2A;GRIN3A;GRIN2C;GRIN2B;GRIA3;GRIN2D;GRIN1;GRIA4,Gluconeogenesis,kegg
Circadian entrainment,9/97,2.9620807843510728E-15,9.2153624402033378E-15,0,0,119.63502673796792,4002.1367203565646,GRIA1;GRIA2;GRIN2A;GRIN2C;GRIN2B;GRIA3;GRIN2D;GRIN1;GRIA4,Gluconeogenesis,kegg
Pathways of neurodegeneration,11/475,6.77100126733227E-12,1.8958803548530356E-11,0,0,30.834770114942529,793.02009273695762,GRIA1;GRIA2;GRM5;GRIN2A;GRIN2C;GRIN2B;GRIA3;GRM1;GRIN2D;GRIN1;GRIA4,Gluconeogenesis,kegg
Phospholipase D signaling pathway,8/148,1.0368113277464964E-11,2.6391561069910816E-11,0,0,62.965079365079362,1592.5307985064196,GRM3;GRM2;GRM5;GRM4;GRM7;GRM6;GRM8;GRM1,Gluconeogenesis,kegg
Alcoholism,7/186,3.0435895584172275E-9,7.101708969640198E-9,0,0,40.74242869744193,798.96832590249448,GRIN3B;GRIN2A;GRIN3A;GRIN2C;GRIN2B;GRIN2D;GRIN1,Gluconeogenesis,kegg
Long-term depression,5/60,1.2842854082470537E-8,2.7661531869936539E-8,0,0,86.229437229437224,1566.8301165171949,GRIA1;GRIA2;GRID2;GRIA3;GRM1,Gluconeogenesis,kegg
Dopaminergic synapse,6/132,1.5227136749626764E-8,3.0454273499253528E-8,0,0,47.25714285714286,850.63739378871389,GRIA1;GRIA2;GRIN2A;GRIN2B;GRIA3;GRIA4,Gluconeogenesis,kegg
Retrograde endocannabinoid signaling,6/148,3.0216826945313574E-8,5.6404743631252007E-8,0,0,41.898591549295773,725.46853530796579,GRIA1;GRIA2;GRM5;GRIA3;GRM1;GRIA4,Gluconeogenesis,kegg
Prion disease,7/273,4.3076850006195842E-8,7.5384487510842727E-8,0,0,27.29639889196676,462.95457111920342,GRIN3B;GRIN2A;GRIN3A;GRIN2C;GRIN2B;GRIN2D;GRIN1,Gluconeogenesis,kegg
Huntington disease,7/306,9.3927238529269762E-8,1.547036869893855E-7,0,0,24.243091005104734,392.27128356841757,GRIA1;GRIA2;GRM5;GRIN2B;GRIA3;GRIN1;GRIA4,Gluconeogenesis,kegg
Amyotrophic lateral sclerosis,7/364,3.0486180993467109E-7,4.742294821205995E-7,0,0,20.244582043343652,303.73770890500936,GRIA1;GRIA2;GRIN2A;GRIN2C;GRIN2B;GRIN2D;GRIN1,Gluconeogenesis,kegg
Calcium signaling pathway,6/240,5.2813720834799465E-7,7.7830746493388675E-7,0,0,25.307692307692307,365.7950999053445,GRM5;GRIN2A;GRIN2C;GRM1;GRIN2D;GRIN1,Gluconeogenesis,kegg
Alzheimer disease,6/369,6.380318243895711E-6,8.9324455414539946E-6,0,0,16.207438016528926,193.87811553182138,GRM5;GRIN2A;GRIN2C;GRIN2B;GRIN2D;GRIN1,Gluconeogenesis,kegg
Rap1 signaling pathway,3/210,2.4827750512871104E-3,3.3103667350494804E-3,0,0,12.455576559546314,74.713261046755107,GRIN2A;GRIN2B;GRIN1,Gluconeogenesis,kegg
Ras signaling pathway,3/232,3.2894759064182873E-3,4.1866056990778203E-3,0,0,11.246440098727929,64.296201989090207,GRIN2A;GRIN2B;GRIN1,Gluconeogenesis,kegg
Taste transduction,2/86,5.5543621266744211E-3,6.7618321542123388E-3,0,0,19.732142857142858,102.47240569174454,GRM4;GRM1,Gluconeogenesis,kegg
Gap junction,2/88,5.808010147143567E-3,6.7760118383341618E-3,0,0,19.271317829457363,99.21871235928316,GRM5;GRM1,Gluconeogenesis,kegg
Systemic lupus erythematosus,2/135,1.3220334980812759E-2,1.4806775178510291E-2,0,0,12.43170426065163,53.779541516860334,GRIN2A;GRIN2B,Gluconeogenesis,kegg
FoxO signaling pathway,1/131,0.15715057276342775,0.1692390783606145,0,0,6.1058461538461541,11.299178918513739,GRM1,Gluconeogenesis,kegg
Estrogen signaling pathway,1/137,0.16374735008097807,0.16981206675064392,0,0,5.8347058823529414,10.557495291482919,GRM1,Gluconeogenesis,kegg
Transcriptional misregulation in cancer,1/192,0.22194874604210998,0.22194874604210998,0,0,4.1430366492146593,6.236549516218437,GRIA3,Gluconeogenesis,kegg
Pentose phosphate pathway,6/30,5.5947766163723002E-16,5.5947766163723004E-15,0,0,1663.9166666666667,58435.96808533265,RPIA;G6PD;RPE;TALDO1;TKT;PGD,Gluconeogenesis,kegg
Glutathione metabolism,4/57,7.38785788259789E-9,3.6939289412989449E-8,0,0,300.95094339622642,5634.8333235346299,G6PD;GPX1;GSR;PGD,Gluconeogenesis,kegg
Thyroid hormone synthesis,2/75,4.9107034593234302E-4,1.6369011531078101E-3,0,0,77.956947162426616,593.9479909744274,GPX1;GSR,Gluconeogenesis,kegg
Diabetic cardiomyopathy,2/203,3.5214002681240811E-3,8.803500670310202E-3,0,0,28.130774697938875,158.90783656283671,G6PD;GSR,Gluconeogenesis,kegg
Pentose and glucuronate interconversions,1/34,1.519926045554118E-2,3.0398520911082361E-2,0,0,75.598484848484844,316.49369990079617,RPE,Gluconeogenesis,kegg
Arachidonic acid metabolism,1/61,2.7122663879516524E-2,4.4383600243343743E-2,0,0,41.522916666666667,149.78917144936761,GPX1,Gluconeogenesis,kegg
Central carbon metabolism in cancer,1/70,3.1068520170340619E-2,4.4383600243343743E-2,0,0,36.090579710144929,125.29061959707016,G6PD,Gluconeogenesis,kegg
Huntington disease,1/306,0.12959081074079043,0.16198851342598802,0,0,8.0680327868852455,16.486003606054858,GPX1,Gluconeogenesis,kegg
Amyotrophic lateral sclerosis,1/364,0.15239609909595578,0.16932899899550644,0,0,6.7589531680440773,12.715430916082402,GPX1,Gluconeogenesis,kegg
Pathways of neurodegeneration,1/475,0.1945647713561883,0.1945647713561883,0,0,5.1468881856540083,8.4254052974273321,GPX1,Gluconeogenesis,kegg
Citrate cycle (TCA cycle),18/30,2.113213639663194E-54,6.1283195550232626E-53,0,0,359460,44426159.317120828,FH;PDHA1;MDH1;MDH2;IDH1;IDH2;SDHC;SDHA;SDHB;CS;SUCLA2;OGDH;SUCLG2;SUCLG1;ACO1;ACO2;DLAT;DLD,Gluconeogenesis,kegg
Glyoxylate and dicarboxylate metabolism,6/30,1.2252452780772944E-13,1.7766056532120768E-12,0,0,415.79166666666669,12361.679658806272,CS;MDH1;MDH2;ACO1;ACO2;DLD,Gluconeogenesis,kegg
Pyruvate metabolism,6/47,2.1965337414058619E-12,2.1233159500256664E-11,0,0,243.1829268292683,6528.0366720706124,FH;PDHA1;MDH1;MDH2;DLAT;DLD,Gluconeogenesis,kegg
Propanoate metabolism,4/34,2.0934843115650383E-8,1.5177761258846528E-7,0,0,190.01904761904763,3359.888474123185,SUCLA2;SUCLG2;SUCLG1;DLD,Gluconeogenesis,kegg
Diabetic cardiomyopathy,4/203,2.8201637279818705E-5,1.3366664911745711E-4,0,0,28.403445800430724,297.55820548377221,PDHA1;SDHC;SDHA;SDHB,Gluconeogenesis,kegg
Glycolysis / Gluconeogenesis,3/67,2.8283417729648286E-5,1.3366664911745711E-4,0,0,62.243749999999999,651.89341300163949,PDHA1;DLAT;DLD,Gluconeogenesis,kegg
Central carbon metabolism in cancer,3/70,3.2264363580075851E-5,1.3366664911745711E-4,0,0,59.447761194029852,614.7818301978358,PDHA1;IDH1;IDH2,Gluconeogenesis,kegg
Oxidative phosphorylation,3/133,2.1805759112672099E-4,7.9045876783436365E-4,0,0,30.541538461538462,257.48811663353064,SDHC;SDHA;SDHB,Gluconeogenesis,kegg
Non-alcoholic fatty liver disease,3/155,3.4201218417955051E-4,1.1020392601341072E-3,0,0,26.092105263157894,208.23233025316819,SDHC;SDHA;SDHB,Gluconeogenesis,kegg
Cysteine and methionine metabolism,2/50,9.1347050624201607E-4,2.6490644681018464E-3,0,0,51.911458333333336,363.28985484182709,MDH1;MDH2,Gluconeogenesis,kegg
Thermogenesis,3/232,1.1053626300749149E-3,2.8654266257762987E-3,0,0,17.251528384279474,117.4411910967076,SDHC;SDHA;SDHB,Gluconeogenesis,kegg
Glutathione metabolism,2/57,1.1856937761832961E-3,2.8654266257762987E-3,0,0,45.288636363636364,305.12889096639515,IDH1;IDH2,Gluconeogenesis,kegg
Parkinson disease,3/249,1.3547819209689829E-3,3.0222058237000388E-3,0,0,16.045528455284554,105.96651164912798,SDHC;SDHA;SDHB,Gluconeogenesis,kegg
Prion disease,3/273,1.7634187705898722E-3,3.652796024793307E-3,0,0,14.601481481481482,92.580706048645709,SDHC;SDHA;SDHB,Gluconeogenesis,kegg
Peroxisome,2/82,2.4346088945992775E-3,4.4234437837820609E-3,0,0,31.096875000000001,187.14003452280946,IDH1;IDH2,Gluconeogenesis,kegg
Huntington disease,3/306,2.4405207082935508E-3,4.4234437837820609E-3,0,0,12.98943894389439,78.13853965009811,SDHC;SDHA;SDHB,Gluconeogenesis,kegg
Amyotrophic lateral sclerosis,3/364,3.982225938925707E-3,6.6658080599352422E-3,0,0,10.870360110803324,60.068678761683714,SDHC;SDHA;SDHB,Gluconeogenesis,kegg
Alzheimer disease,3/369,4.1373981061667018E-3,6.6658080599352422E-3,0,0,10.71912568306011,58.823219155334804,SDHC;SDHA;SDHB,Gluconeogenesis,kegg
Pathways of neurodegeneration,3/475,8.3293254215131736E-3,1.2713180906520108E-2,0,0,8.2669491525423737,39.581927746613026,SDHC;SDHA;SDHB,Gluconeogenesis,kegg
Proximal tubule bicarbonate reclamation,1/23,2.0507371457078361E-2,2.9735688612763624E-2,0,0,53.36898395721925,207.44368622737056,MDH1,Gluconeogenesis,kegg
"Glycine, serine and threonine metabolism",1/40,3.5409072945574091E-2,4.889824359150708E-2,0,0,30.079939668174962,100.49067723322013,DLD,Gluconeogenesis,kegg
Tryptophan metabolism,1/42,3.7148070085386981E-2,4.8967910567101015E-2,0,0,28.609756097560975,94.207448212762941,DLD,Gluconeogenesis,kegg
"Valine, leucine and isoleucine degradation",1/48,4.2347313814152854E-2,5.3394439156975337E-2,0,0,24.949937421777221,78.887966825945881,DLD,Gluconeogenesis,kegg
Lysine degradation,1/63,5.522966630423428E-2,6.6735846784283084E-2,0,0,18.89943074003795,54.737571477584737,DLD,Gluconeogenesis,kegg
Renal cell carcinoma,1/69,6.033663736484967E-2,6.9990499343225612E-2,0,0,17.226643598615915,48.3692416453001,FH,Gluconeogenesis,kegg
Glucagon signaling pathway,1/107,9.2080312987244992E-2,0.10066507259667325,0,0,11.029966703662597,26.307508679008535,PDHA1,Gluconeogenesis,kegg
HIF-1 signaling pathway,1/109,9.3722653796902672E-2,0.10066507259667325,0,0,10.824618736383442,25.626368549164901,PDHA1,Gluconeogenesis,kegg
Cushing syndrome,1/155,0.1307310829477655,0.13540005019589998,0,0,7.5737203972498088,15.409588975790413,FH,Gluconeogenesis,kegg
Pathways in cancer,1/531,0.38403586589300343,0.38403586589300343,0,0,2.1589345172031078,2.066142065152393,FH,Gluconeogenesis,kegg
Oxidative phosphorylation,2/133,2.3209742239260786E-3,1.8809716293279342E-2,0,0,33.686174724342663,204.33252935417062,UQCR10;SDHA,Gluconeogenesis,kegg
Non-alcoholic fatty liver disease,2/155,3.1349527155465568E-3,1.8809716293279342E-2,0,0,28.81045751633987,166.0963552659853,UQCR10;SDHA,Gluconeogenesis,kegg
Diabetic cardiomyopathy,2/203,5.3085063609301002E-3,1.8826375641053893E-2,0,0,21.877280265339966,114.60292441530726,UQCR10;SDHA,Gluconeogenesis,kegg
Thermogenesis,2/232,6.8777543459550153E-3,1.8826375641053893E-2,0,0,19.090821256038648,95.062039678565696,UQCR10;SDHA,Gluconeogenesis,kegg
Parkinson disease,2/249,7.8846591208393806E-3,1.8826375641053893E-2,0,0,17.761583445793971,86.016440894203825,UQCR10;SDHA,Gluconeogenesis,kegg
Prion disease,2/273,9.4131878205269467E-3,1.8826375641053893E-2,0,0,16.168921689216891,75.438426213307352,UQCR10;SDHA,Gluconeogenesis,kegg
Huntington disease,2/306,1.1714596681928544E-2,2.0070341143561286E-2,0,0,14.389619883040936,63.989483199624374,UQCR10;SDHA,Gluconeogenesis,kegg
Amyotrophic lateral sclerosis,2/364,1.6298912453850758E-2,2.0070341143561286E-2,0,0,12.048496009821976,49.599524161381915,UQCR10;SDHA,Gluconeogenesis,kegg
Citrate cycle (TCA cycle),1/30,1.6380733950540891E-2,2.0070341143561286E-2,0,0,68.827586206896555,282.99490310676202,SDHA,Gluconeogenesis,kegg
Alzheimer disease,2/369,1.6725284286301073E-2,2.0070341143561286E-2,0,0,11.881320012110203,48.604504014054939,UQCR10;SDHA,Gluconeogenesis,kegg
Pathways of neurodegeneration,2/475,2.6863684936389024E-2,2.9305838112424386E-2,0,0,9.1688982851773542,33.16372086510065,UQCR10;SDHA,Gluconeogenesis,kegg
Cardiac muscle contraction,1/87,4.6833951764574382E-2,4.6833951764574382E-2,0,0,23.143023255813954,70.844193295048214,UQCR10,Gluconeogenesis,kegg
Fatty acid biosynthesis,6/18,5.8416400618889386E-18,5.8416400618889388E-17,0,0,4995,198209.19281939781,OLAH;FASN;MCAT;ACACB;ACACA;CBR4,Gluconeogenesis,kegg
AMPK signaling pathway,3/120,1.153988610253748E-5,5.7236846896685334E-5,0,0,101.92307692307692,1158.8349266090672,FASN;ACACB;ACACA,Gluconeogenesis,kegg
Insulin signaling pathway,3/137,1.7171054069005599E-5,5.7236846896685334E-5,0,0,88.916417910447763,975.61632248674584,FASN;ACACB;ACACA,Gluconeogenesis,kegg
Fatty acid elongation,2/27,4.8894965278531189E-5,1.2223741319632799E-4,0,0,266.22666666666669,2642.5222657906538,PPT1;PPT2,Gluconeogenesis,kegg
Propanoate metabolism,2/34,7.8039306520185809E-5,1.5607861304037162E-4,0,0,207.91666666666666,1966.537777625364,ACACB;ACACA,Gluconeogenesis,kegg
Pyruvate metabolism,2/47,1.4998531968970716E-4,2.4997553281617859E-4,0,0,147.75555555555556,1300.9836975672104,ACACB;ACACA,Gluconeogenesis,kegg
Glucagon signaling pathway,2/107,7.7744677773607541E-4,1.1106382539086792E-3,0,0,63.133333333333333,452.0028076501448,ACACB;ACACA,Gluconeogenesis,kegg
Lysosome,2/128,1.1096058245021485E-3,1.3870072806276856E-3,0,0,52.555555555555557,357.57488422434,PPT1;PPT2,Gluconeogenesis,kegg
Adipocytokine signaling pathway,1/69,2.7273557473830964E-2,3.0303952748701072E-2,0,0,41.857142857142854,150.7626325151401,ACACB,Gluconeogenesis,kegg
Insulin resistance,1/108,4.2399339108608228E-2,4.2399339108608228E-2,0,0,26.548731642189587,83.910518679018736,ACACB,Gluconeogenesis,kegg
Fatty acid degradation,8/43,2.2843778091728843E-22,4.1118800565111917E-21,0,0,159656,7955782.7485956615,CPT1A;ACADVL;ECHS1;CPT2;ACADL;ACSL1;ACSL3;ACADS,Gluconeogenesis,kegg
PPAR signaling pathway,5/74,3.3544869066147825E-11,3.0190382159533043E-10,0,0,481.231884057971,11606.416603835018,CPT1A;CPT2;ACADL;ACSL1;ACSL3,Gluconeogenesis,kegg
Thermogenesis,4/232,1.1907539536763027E-6,7.1445237220578162E-6,0,0,86.684210526315795,1182.4527171226812,CPT1A;CPT2;ACSL1;ACSL3,Gluconeogenesis,kegg
Adipocytokine signaling pathway,3/69,2.1736023862629252E-6,9.7812107381831635E-6,0,0,181.14545454545456,2361.978167213847,CPT1A;ACSL1;ACSL3,Gluconeogenesis,kegg
Fatty acid biosynthesis,2/18,2.1351432280008236E-5,7.6865156208029656E-5,0,0,416.16666666666669,4475.619360309719,ACSL1;ACSL3,Gluconeogenesis,kegg
Butanoate metabolism,2/28,5.2645617296768729E-5,1.5572591716433008E-4,0,0,255.97435897435898,2521.8408431320772,ECHS1;ACADS,Gluconeogenesis,kegg
beta-Alanine metabolism,2/30,6.0560078897239473E-5,1.5572591716433008E-4,0,0,237.66666666666666,2308.1888742091614,ECHS1;ACADS,Gluconeogenesis,kegg
Propanoate metabolism,2/34,7.8039306520185809E-5,1.7558843967041806E-4,0,0,207.91666666666666,1966.537777625364,ECHS1;ACADS,Gluconeogenesis,kegg
Ferroptosis,2/41,1.1390884044388589E-4,2.2781768088777179E-4,0,0,170.53846153846155,1548.5083438136971,ACSL1;ACSL3,Gluconeogenesis,kegg
"Valine, leucine and isoleucine degradation",2/48,1.5647515348005239E-4,2.816552762640943E-4,0,0,144.53623188405797,1266.5151113505071,ECHS1;ACADS,Gluconeogenesis,kegg
Peroxisome,2/82,4.5756487514379021E-4,7.4874252296256588E-4,0,0,82.966666666666669,637.97980628651453,ACSL1;ACSL3,Gluconeogenesis,kegg
Fatty acid elongation,1/27,1.0750872860949598E-2,1.6126309291424397E-2,0,0,109.7032967032967,497.25962914000377,ECHS1,Gluconeogenesis,kegg
Tryptophan metabolism,1/42,1.6679797556906864E-2,2.3095104309563349E-2,0,0,69.515679442508713,284.56639751252425,ECHS1,Gluconeogenesis,kegg
Lysine degradation,1/63,2.492805820599394E-2,3.2050360550563636E-2,0,0,45.921658986175117,169.5318022982446,ECHS1,Gluconeogenesis,kegg
Glucagon signaling pathway,1/107,4.2014084646480689E-2,4.7699256497184254E-2,0,0,26.80053908355795,84.951018627794397,CPT1A,Gluconeogenesis,kegg
Insulin resistance,1/108,4.2399339108608228E-2,4.7699256497184254E-2,0,0,26.548731642189587,83.910518679018736,CPT1A,Gluconeogenesis,kegg
AMPK signaling pathway,1/120,4.7011830274227381E-2,4.9777232055064284E-2,0,0,23.857142857142858,72.939778880592712,CPT1A,Gluconeogenesis,kegg
Diabetic cardiomyopathy,1/203,7.8386136829956946E-2,7.8386136829956946E-2,0,0,13.995756718528996,35.634710854017911,CPT2,Gluconeogenesis,kegg
Synthesis and degradation of ketone bodies,4/10,4.7223345809444108E-13,4.722334580944411E-12,0,0,6662.666666666667,189095.16090166365,BDH2;HMGCS1;BDH1;HMGCS2,Gluconeogenesis,kegg
Butanoate metabolism,4/28,4.5981690605313917E-11,2.299084530265696E-10,0,0,1664.1666666666667,39611.789437083862,BDH2;HMGCS1;BDH1;HMGCS2,Gluconeogenesis,kegg
"Valine, leucine and isoleucine degradation",4/48,4.3629918321547479E-10,1.4543306107182493E-9,0,0,906.81818181818187,19544.373796001761,ACAA2;HMGCS1;HMGCS2;ACAA1,Gluconeogenesis,kegg
PPAR signaling pathway,3/74,9.6467001367312016E-7,2.4116750341828003E-6,0,0,280.6056338028169,3886.8032540273707,HMGCS1;HMGCS2;ACAA1,Gluconeogenesis,kegg
Terpenoid backbone biosynthesis,2/22,1.7278715595310902E-5,3.4557431190621804E-5,0,0,499.35,5475.88964033087,HMGCS1;HMGCS2,Gluconeogenesis,kegg
Fatty acid degradation,2/43,6.7355955097256852E-5,1.1225992516209476E-4,0,0,243.32926829268294,2337.3039679641729,ACAA2;ACAA1,Gluconeogenesis,kegg
alpha-Linolenic acid metabolism,1/25,7.4774468101390743E-3,8.9706965453475E-3,0,0,166.41666666666666,814.7533474976135,ACAA1,Gluconeogenesis,kegg
Biosynthesis of unsaturated fatty acids,1/27,8.0736268908127504E-3,8.9706965453475E-3,0,0,153.6,740.22181920983223,ACAA1,Gluconeogenesis,kegg
Fatty acid elongation,1/27,8.0736268908127504E-3,8.9706965453475E-3,0,0,153.6,740.22181920983223,ACAA2,Gluconeogenesis,kegg
Peroxisome,1/82,2.4352069500002304E-2,2.4352069500002304E-2,0,0,49.1679012345679,182.66556005448462,ACAA1,Gluconeogenesis,kegg
Arginine and proline metabolism,4/50,5.1631175307671027E-10,4.1304940246136822E-9,0,0,867.304347826087,18546.705350712906,OAT;CKM;GOT2;CKB,Gluconeogenesis,kegg
"Phenylalanine, tyrosine and tryptophan biosynthesis",1/6,1.7988408901478401E-3,7.1953635605913604E-3,0,0,799.56,5053.7091475187217,GOT2,Gluconeogenesis,kegg
Phenylalanine metabolism,1/17,5.0897414535705718E-3,1.3165234295857335E-2,0,0,249.72499999999999,1318.6799159042428,GOT2,Gluconeogenesis,kegg
Arginine biosynthesis,1/22,6.5826171479286674E-3,1.3165234295857335E-2,0,0,190.21904761904761,955.5316921910462,GOT2,Gluconeogenesis,kegg
Tyrosine metabolism,1/36,1.0752747305294047E-2,1.4665528842802917E-2,0,0,114.05142857142857,516.94882012443327,GOT2,Gluconeogenesis,kegg
"Alanine, aspartate and glutamate metabolism",1/37,1.1050054899886797E-2,1.4665528842802917E-2,0,0,110.87777777777778,499.53985677349652,GOT2,Gluconeogenesis,kegg
Fat digestion and absorption,1/43,1.2832337737452553E-2,1.4665528842802917E-2,0,0,95.009523809523813,413.84123997008294,GOT2,Gluconeogenesis,kegg
Cysteine and methionine metabolism,1/50,1.4908284799373634E-2,1.4908284799373634E-2,0,0,81.408163265306129,342.38956234448409,GOT2,Gluconeogenesis,kegg
Starch and sucrose metabolism,9/36,1.4632873350373728E-23,8.6333952767204986E-22,0,0,2217.8888888888887,116613.87340036755,GYS2;GYS1;HK3;UGP2;GBE1;PGM2;HK2;PGM1;HK1,Gluconeogenesis,kegg
Galactose metabolism,6/31,7.6064229462400323E-15,2.2438947691408096E-13,0,0,798.52,25959.712224621369,HK3;UGP2;PGM2;HK2;PGM1;HK1,Gluconeogenesis,kegg
Amino sugar and nucleotide sugar metabolism,6/48,1.2623197516636954E-13,2.4825621782719346E-12,0,0,474.90476190476193,14104.982542436219,HK3;UGP2;PGM2;HK2;PGM1;HK1,Gluconeogenesis,kegg
Insulin signaling pathway,6/137,8.2633651364663462E-11,1.2188463576287862E-9,0,0,151.58015267175571,3519.1763965530226,GYS2;GSK3B;GYS1;HK3;HK2;HK1,Gluconeogenesis,kegg
Glycolysis / Gluconeogenesis,5/67,2.8176024730614788E-10,3.3247709182125453E-9,0,0,229.56221198156683,5048.0649134714467,HK3;PGM2;HK2;PGM1;HK1,Gluconeogenesis,kegg
"Neomycin, kanamycin and gentamicin biosynthesis",3/5,1.6488119692692557E-9,1.6213317697814349E-8,0,0,3331,67363.5152647254,HK3;HK2;HK1,Gluconeogenesis,kegg
Shigellosis,5/246,1.9952111630469792E-7,1.681677980282454E-6,0,0,58.526970954356848,902.91581720296176,GSK3B;HK3;GSK3A;HK2;HK1,Gluconeogenesis,kegg
Fructose and mannose metabolism,3/33,8.9121679720243694E-7,6.5727238793679728E-6,0,0,221.75555555555556,3089.2052657889908,HK3;HK2;HK1,Gluconeogenesis,kegg
Type II diabetes mellitus,3/46,2.468761439877347E-6,1.5553564504656339E-5,0,0,154.6124031007752,1996.323494729249,HK3;HK2;HK1,Gluconeogenesis,kegg
Carbohydrate digestion and absorption,3/47,2.6361973736705659E-6,1.5553564504656339E-5,0,0,151.09090909090909,1940.9399671718354,HK3;HK2;HK1,Gluconeogenesis,kegg
Central carbon metabolism in cancer,3/70,8.8307241576343839E-6,4.7364793209129872E-5,0,0,99.109452736318403,1153.3638114615098,HK3;HK2;HK1,Gluconeogenesis,kegg
Insulin resistance,3/108,3.2514692610949381E-5,1.5169182367720852E-4,0,0,63.12063492063492,652.27718427175091,GYS2;GSK3B;GYS1,Gluconeogenesis,kegg
HIF-1 signaling pathway,3/109,3.3423622166164591E-5,1.5169182367720852E-4,0,0,62.522012578616355,644.36734567938822,HK3;HK2;HK1,Gluconeogenesis,kegg
Pentose phosphate pathway,2/30,1.4221789991262262E-4,5.9934686391748101E-4,0,0,142.57142857142858,1262.9191242496929,PGM2;PGM1,Gluconeogenesis,kegg
Diabetic cardiomyopathy,3/203,2.1186114607253252E-4,8.333205078852945E-4,0,0,32.979999999999997,278.99693089539278,GYS2;GSK3B;GYS1,Gluconeogenesis,kegg
PI3K-Akt signaling pathway,3/354,1.0742113111589966E-3,3.9611542098988003E-3,0,0,18.648622981956315,127.48512994318227,GYS2;GSK3B;GYS1,Gluconeogenesis,kegg
Glucagon signaling pathway,2/107,1.8071154231623758E-3,6.2717535274458922E-3,0,0,37.872380952380951,239.20284407557955,GYS2;GYS1,Gluconeogenesis,kegg
AMPK signaling pathway,2/120,2.2653928936461438E-3,7.4254544847290266E-3,0,0,33.677966101694913,205.09905173365922,GYS2;GYS1,Gluconeogenesis,kegg
Purine metabolism,2/129,2.6116372501194455E-3,8.0602102911259115E-3,0,0,31.277165354330709,186.02963460254267,PGM2;PGM1,Gluconeogenesis,kegg
Dopaminergic synapse,2/132,2.7322746749579357E-3,8.0602102911259115E-3,0,0,30.55076923076923,180.32960599224347,GSK3B;GSK3A,Gluconeogenesis,kegg
Non-alcoholic fatty liver disease,2/155,3.742863591746855E-3,1.0515664376812593E-2,0,0,25.928104575163399,144.88376689825418,GSK3B;GSK3A,Gluconeogenesis,kegg
Chemokine signaling pathway,2/192,5.6798092691881406E-3,1.5232215767368194E-2,0,0,20.84,107.76025612961541,GSK3B;GSK3A,Gluconeogenesis,kegg
Pentose and glucuronate interconversions,1/34,2.0215692219209058E-2,5.1857645257971055E-2,0,0,54.972451790633606,214.46381362673279,UGP2,Gluconeogenesis,kegg
Hedgehog signaling pathway,1/56,3.309612573679984E-2,8.0852051497612432E-2,0,0,32.947107438016531,112.2949128878184,GSK3B,Gluconeogenesis,kegg
Endometrial cancer,1/58,3.4259343854920521E-2,8.0852051497612432E-2,0,0,31.787878787878789,107.24581633848625,GSK3B,Gluconeogenesis,kegg
Basal cell carcinoma,1/63,3.7161779576272667E-2,8.4328653653849506E-2,0,0,29.217008797653961,96.196255749374828,GSK3B,Gluconeogenesis,kegg
Prolactin signaling pathway,1/70,4.1211757984317837E-2,9.0055323002768611E-2,0,0,26.243741765480895,83.692123770432559,GSK3B,Gluconeogenesis,kegg
B cell receptor signaling pathway,1/81,4.7544470857634545E-2,9.9140222405060277E-2,0,0,22.622727272727271,68.910858281195161,GSK3B,Gluconeogenesis,kegg
ErbB signaling pathway,1/85,4.9837753350796807E-2,9.9140222405060277E-2,0,0,21.541125541125542,64.601458156557385,GSK3B,Gluconeogenesis,kegg
Colorectal cancer,1/86,5.0410282578844209E-2,9.9140222405060277E-2,0,0,21.286631016042779,63.595089599609956,GSK3B,Gluconeogenesis,kegg
IL-17 signaling pathway,1/94,5.4979145063769622E-2,0.10451714865194368,0,0,19.44770283479961,56.41392256593172,GSK3B,Gluconeogenesis,kegg
Prostate cancer,1/97,5.6687267065460983E-2,0.10451714865194368,0,0,18.837121212121211,54.066411925168218,GSK3B,Gluconeogenesis,kegg
Melanogenesis,1/101,5.8960360820228652E-2,0.10526621213916339,0,0,18.079999999999998,51.182489597636589,GSK3B,Gluconeogenesis,kegg
T cell receptor signaling pathway,1/104,6.0661884961551782E-2,0.10526621213916339,0,0,17.550750220653132,49.1849192357055,GSK3B,Gluconeogenesis,kegg
Neurotrophin signaling pathway,1/119,6.9127282107932897E-2,0.11168622824329165,0,0,15.308166409861325,40.900447884891058,GSK3B,Gluconeogenesis,kegg
"Growth hormone synthesis, secretion and action",1/119,6.9127282107932897E-2,0.11168622824329165,0,0,15.308166409861325,40.900447884891058,GSK3B,Gluconeogenesis,kegg
Thyroid hormone signaling pathway,1/121,7.0250702466731596E-2,0.11168622824329165,0,0,15.051515151515151,39.97208258305033,GSK3B,Gluconeogenesis,kegg
Cell cycle,1/124,7.1933502936357335E-2,0.11168622824329165,0,0,14.682187730968218,38.643711282161568,GSK3B,Gluconeogenesis,kegg
Yersinia infection,1/137,7.9193425149914884E-2,0.11576946218640972,0,0,13.270053475935828,33.651024339520887,GSK3B,Gluconeogenesis,kegg
Measles,1/139,8.0305704143177725E-2,0.11576946218640972,0,0,13.076416337285902,32.977605605491178,GSK3B,Gluconeogenesis,kegg
Signaling pathways regulating pluripotency of stem cells,1/143,8.2526568247849305E-2,0.11576946218640972,0,0,12.70550576184379,31.695599342274981,GSK3B,Gluconeogenesis,kegg
Breast cancer,1/147,8.4742515404808719E-2,0.11576946218640972,0,0,12.354919053549191,30.493643355051663,GSK3B,Gluconeogenesis,kegg
Gastric cancer,1/149,8.5848648228948846E-2,0.11576946218640972,0,0,12.186732186732186,29.920492407790988,GSK3B,Gluconeogenesis,kegg
mTOR signaling pathway,1/154,8.8608621324746548E-2,0.11576946218640972,0,0,11.785502079619727,28.562472126761907,GSK3B,Gluconeogenesis,kegg
Cushing syndrome,1/155,8.9159698490051134E-2,0.11576946218640972,0,0,11.708382526564344,28.302979280758233,GSK3B,Gluconeogenesis,kegg
Hepatitis C,1/157,9.0260936619912677E-2,0.11576946218640972,0,0,11.557109557109557,27.795432208182255,GSK3B,Gluconeogenesis,kegg
Hippo signaling pathway,1/163,9.3557332354280029E-2,0.1159481981182133,0,0,11.125701459034792,26.358798843411972,GSK3B,Gluconeogenesis,kegg
Wnt signaling pathway,1/166,9.5201421086498289E-2,0.1159481981182133,0,0,10.92176308539945,25.685370030735868,GSK3B,Gluconeogenesis,kegg
Hepatocellular carcinoma,1/168,9.6295961149024611E-2,0.1159481981182133,0,0,10.78987479586282,25.251855826797005,GSK3B,Gluconeogenesis,kegg
Axon guidance,1/182,0.10392382237785831,0.12263011040587281,0,0,9.9482672024108485,22.523843175382979,GSK3B,Gluconeogenesis,kegg
Kaposi sarcoma-associated herpesvirus infection,1/193,0.10987568860765264,0.12711109074218641,0,0,9.3731060606060606,20.699620436703082,GSK3B,Gluconeogenesis,kegg
Focal adhesion,1/201,0.11418153310963532,0.12955212410516315,0,0,8.9945454545454542,19.517855136107741,GSK3B,Gluconeogenesis,kegg
Lipid and atherosclerosis,1/215,0.12167084620216879,0.13544490426279168,0,0,8.4001699235344098,17.694419176440732,GSK3B,Gluconeogenesis,kegg
Human cytomegalovirus infection,1/225,0.126984770088551,0.13874261917082423,0,0,8.021103896103897,16.553056821898632,GSK3B,Gluconeogenesis,kegg
Prion disease,1/273,0.15208378767324121,0.16314442677674967,0,0,6.5895721925133692,12.410297320374392,GSK3B,Gluconeogenesis,kegg
Human papillomavirus infection,1/331,0.18152860965592338,0.19125335660177642,0,0,5.415426997245179,9.2405705806702034,GSK3B,Gluconeogenesis,kegg
Alzheimer disease,1/369,0.20030863276862923,0.20733700584823028,0,0,4.8468379446640313,7.7932110435864779,GSK3B,Gluconeogenesis,kegg
Pathways of neurodegeneration,1/475,0.25062715666941721,0.25494831454302785,0,0,3.7426160337552741,5.1789904338772033,GSK3B,Gluconeogenesis,kegg
Pathways in cancer,1/531,0.27602265183294583,0.27602265183294583,0,0,3.3375643224699827,4.2963542512206434,GSK3B,Gluconeogenesis,kegg
Starch and sucrose metabolism,7/36,1.1805621270710007E-18,1.7708431906065011E-17,0,0,2409.2068965517242,99453.36399824715,PYGB;G6PC2;G6PC3;PGM2;PYGM;PYGL;PGM1,Gluconeogenesis,kegg
Glucagon signaling pathway,5/107,4.9396048405781089E-10,2.2182505224366405E-9,0,0,243.73774509803923,5222.9502585001883,PYGB;G6PC2;G6PC3;PYGM;PYGL,Gluconeogenesis,kegg
Insulin resistance,5/108,5.178529645120476E-10,2.2182505224366405E-9,0,0,241.35922330097088,5160.5811455255007,PYGB;G6PC2;G6PC3;PYGM;PYGL,Gluconeogenesis,kegg
Galactose metabolism,4/31,5.915334726497708E-10,2.2182505224366405E-9,0,0,591.52592592592589,12568.922014552623,G6PC2;G6PC3;PGM2;PGM1,Gluconeogenesis,kegg
Insulin signaling pathway,5/137,1.7271149886507662E-9,5.181344965952299E-9,0,0,188.05871212121212,3794.4255534537783,PYGB;G6PC2;G6PC3;PYGM;PYGL,Gluconeogenesis,kegg
Glycolysis / Gluconeogenesis,4/67,1.4306907436567586E-8,3.5767268591418962E-8,0,0,253.05396825396826,4570.7932176812164,G6PC2;G6PC3;PGM2;PGM1,Gluconeogenesis,kegg
Necroptosis,3/159,3.9986141120513278E-5,8.5684588115385589E-5,0,0,63.573717948717949,643.80961989595141,PYGB;PYGM;PYGL,Gluconeogenesis,kegg
Pentose phosphate pathway,2/30,7.7790489973988207E-5,1.458571687012279E-4,0,0,203.70408163265307,1927.3444106230902,PGM2;PGM1,Gluconeogenesis,kegg
Carbohydrate digestion and absorption,2/47,1.9254963508295519E-4,3.0131178430402311E-4,0,0,126.64126984126985,1083.4358946139766,G6PC2;G6PC3,Gluconeogenesis,kegg
Amino sugar and nucleotide sugar metabolism,2/48,2.0087452286934873E-4,3.0131178430402311E-4,0,0,123.88198757763975,1054.5863138348677,PGM2;PGM1,Gluconeogenesis,kegg
Adipocytokine signaling pathway,2/69,4.1573510553512564E-4,5.6691150754789859E-4,0,0,84.96375266524521,661.48209035853381,G6PC2;G6PC3,Gluconeogenesis,kegg
AMPK signaling pathway,2/120,1.2503080539860466E-3,1.5628850674825584E-3,0,0,48.118644067796609,321.64259540397012,G6PC2;G6PC3,Gluconeogenesis,kegg
Purine metabolism,2/129,1.4426991132955526E-3,1.5934964944079519E-3,0,0,44.688413948256468,292.3176201028142,PGM2;PGM1,Gluconeogenesis,kegg
FoxO signaling pathway,2/131,1.4872633947807551E-3,1.5934964944079519E-3,0,0,43.991140642303435,286.41828814216444,G6PC2;G6PC3,Gluconeogenesis,kegg
PI3K-Akt signaling pathway,2/354,1.0358818281433778E-2,1.0358818281433778E-2,0,0,15.940746753246753,72.847891400080002,G6PC2;G6PC3,Gluconeogenesis,kegg
Arginine biosynthesis,6/22,2.3472056910959181E-17,1.6430439837671427E-16,0,0,3745.5,143417.89560986188,ARG2;CPS1;ARG1;ASL;ASS1;OTC,Gluconeogenesis,kegg
"Alanine, aspartate and glutamate metabolism",4/37,6.8987798741338331E-10,2.4145729559468417E-9,0,0,604.81818181818187,12758.340985311122,CPS1;CAD;ASL;ASS1,Gluconeogenesis,kegg
Arginine and proline metabolism,3/50,8.1601679509225178E-7,1.9040391885485876E-6,0,0,254.61702127659575,3569.4329655314791,ARG2;ARG1;AGMAT,Gluconeogenesis,kegg
Amoebiasis,2/102,7.0686620991638712E-4,1.2370158673536775E-3,0,0,66.306666666666672,481.03292886084796,ARG2;ARG1,Gluconeogenesis,kegg
Nitrogen metabolism,1/17,6.7809060200976099E-3,9.4932684281366538E-3,0,0,178.35714285714286,890.65217521593831,CPS1,Gluconeogenesis,kegg
Pyrimidine metabolism,1/56,2.2185389719098877E-2,2.5882954672282025E-2,0,0,51.784415584415584,197.21169430337935,CAD,Gluconeogenesis,kegg
Fluid shear stress and atherosclerosis,1/139,5.4275189323567431E-2,5.4275189323567431E-2,0,0,20.552795031055901,59.884433789824605,ASS1,Gluconeogenesis,kegg
